Human telomerase reverse transcriptase is a promising target for cancer inhibition in squamous cell carcinomas

Young-Jin Park1, Eun-Kyoung Kim1, Sook Moon1

  • 1Department of Oral Pathology, Oral Cancer Research Institute and Brain Korea PLUS 21 Project, College of Dentistry, Yonsei University, Seoul, Republic of Korea.

Anticancer Research
|November 5, 2014
PubMed
Abstract

Insights

Down-regulating human telomerase reverse transcriptase (hTERT) in oral cancer cells reduced their invasion and matrix metalloproteinase (MMP) expression. This suggests hTERT is a potential therapeutic target for oral squamous cell carcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Oral squamous cell carcinoma (OSCC) is a prevalent cancer.
  • Human telomerase reverse transcriptase (hTERT) is often overexpressed in cancer cells, contributing to their proliferation and invasiveness.

Purpose of the Study:

  • To investigate the effect of down-regulating human telomerase reverse transcriptase (hTERT) on the invasive properties of oral squamous cell carcinoma cell lines.
  • To explore the potential of targeting hTERT as a therapeutic strategy for oral cancer.

Main Methods:

  • Utilized a genetically-engineered squamous carcinoma cell line (IHOK) overexpressing hTERT.
  • Assessed in vivo tumorigenicity using an orthotopic xenograft model in nude mice.
  • Evaluated anti-invasive activity via transwell invasion assays and real-time PCR for matrix metalloproteinases (MMPs) following hTERT knockdown.

Main Results:

  • Down-regulation of hTERT expression significantly reduced the invasive activity of oral cancer cells.
  • hTERT knockdown led to decreased expression of matrix metalloproteinases (MMPs).
  • These findings were validated in the HSC3 oral squamous carcinoma cell line.

Conclusions:

  • Targeting hTERT demonstrates an anti-invasive effect in oral squamous cell carcinoma.
  • Inhibition of hTERT may represent a promising therapeutic approach for oral cancer treatment.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.5K
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
22.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
6.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K